Ví dụ về việc sử dụng Potent agonist trong Tiếng anh và bản dịch của chúng sang Tiếng việt
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Androstanolone is a potent agonist of the AR.
It is a potent agonist of theCB1 receptor with a binding affinity of Ki= 0.289 nM and was originally developed by Pfizer in 2009 as an analgesicmedication.
Nefiracetam powder is a potent agonist for the GABA receptors.
Dimethandrolone is an AAS, though it has also been described as a selective androgen receptor modulator(SARM).[1][2][3] As an AAS,it is a potent agonist of the androgen receptor(AR).[1][2].
Bromocriptine is a potent agonist at dopamine D2 receptors[18] and various serotonin receptors.
It binds strongly to the androgen receptor and is a more potent agonist of the androgen receptor than is DHT.
Buy 5F-ADBBuy 5F-ADB is a potent agonist of the CB1 receptor, though it is unclear whether it is selective for this target.
AMB-FUBINACA(also known as FUB-AMB and MMB-FUBINACA)is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.
F-AB-PINACA has been reported to be a potent agonist of the CB1 receptor and CB2 receptor with EC50 values of 0.48 nM and 2.6 nM respectively.
E1S itself is essentially biologically inactive, with less than 1% of the relative binding affinity of estradiol for the estrogen receptors(ERs), ERα and ERβ.[7] The compound acts as a prodrug of estrone and more importantly of estradiol,the latter of which is a potent agonist of the ERs.[2] Hence, E1S is an estrogen.
It binds strongly to the androgen receptor(AR) and is a more potent agonist(activator) of the androgen receptor than is DHT.
It is a potent agonist of the CB1receptor(Ki= 0.78 nM) and CB2receptor(Ki= 0.45 nM) and fully substitutes for Δ9-THC in rat discrimination studies, while being 16x more potent. .
LSD, mescaline, and components of the psilocybin mushroom are potent agonists that bind to 5-HT2A- and when that happens get ready for the magical mystery tour.
AB-PINACA acts as a potent agonist for the CB1 receptor(Ki= 2.87 nM, EC50= 1.2 nM) and CB2 receptor(Ki= 0.88 nM, EC50= 2.5 nM) and fully substitutes for Δ9-THC in rat discrimination studies, while being 1.5x more potent. .
MDMB-CHMICA(also incorrectly known as MMB-CHMINACA)is an indole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug.
Rosiglitazone acts as a highly selective and potent agonist at peroxisome proliferator activated receptors(PPAR) in target tissues for insulin action such as adipose tissue, skeletal muscle, and liver.
The(S) enantiomer of ADB-FUBINACA is claimed in Pfizer patent WO 2009/106982 andhas been reported to be a potent agonist of the CB1receptor and CB2 receptor with an EC50 value of 1.2 nM and 3.5 nM respectively.
Buy 5F-ADB from Canna-Noids that is a potent agonist of the CB1 receptor, though it is unclear whether it is selective for this target.
Like cromoglicic acid it acts as a mast cell stabilizer.[1]In 2014 lodoxamide and bufrolin were found to be potent agonists at the G protein-coupled receptor 35, an orphan receptor believed to play a role in inflammatory processes, pain and the development of stomach cancer.[2].
An in vitro yeast structure-activity relationships bioassay study found that altrenogest was the most potent agonist of both the progesterone receptor( PR) and the androgen receptor( AR) of a large selection of other progestogens as well as anabolic- androgenic steroids( AAS).
NS-2664 is a potent but non-selective partial agonist at GABAA receptors, although with little efficacy at the α1 subtype and more at α2 and α3.
Leuprolide acetate powder is a potent gonadotropin-releasing hormone receptor(GnRHR) agonist, and it has proven to be essential in different clinical applications.
Imidazenil is a highly potent benzodiazepine receptor partial agonist[2] with an unusual profile of effects, producing some of the effects associated with normal benzodiazepines such as anticonvulsant and anxiolytic effects, yet without any notable sedative or amnestic[3] effects.
UK-432,097 is a drug developed by Pfizer for the treatment of chronic obstructive pulmonary disease,which acts as a potent and selective agonist of the adenosine A2A receptor.[1] It was discontinued from clinical trials following poor efficacy results,[2] but its high selectivity has made it useful for detailed mapping of the internal structure of the A2A receptor.[3].
Nafarelin acetate is a potent LHRH agonist. .
A cell-permeable, thiazolyl compound that acts as a potent, high affinity, PPARδ agonist. .
Nemonapride acts as a D2 and D3 receptor antagonist,and is also a potent 5-HT1A receptor agonist. .
GW-501516 is a selective agonist with high affinity and it is very potent.